• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病特异性癌症护理路径中的癌症护理成本评估。

Assessment of Cancer Care Costs in Disease-Specific Cancer Care Pathways.

机构信息

Healthcare Administration, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Management and Accounting Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

出版信息

Int J Environ Res Public Health. 2020 Jul 2;17(13):4765. doi: 10.3390/ijerph17134765.

DOI:10.3390/ijerph17134765
PMID:32630745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7369964/
Abstract

In view of an efficient use of the Italian National Health Service-funded healthcare resources, a novel data-processing strategy combining information from multiple sources was developed in a regional cancer network of northern Italy. The goal was to calculate the annual overall cost of care pathways of six disease groups in 10,486 patients. The evaluation was conceived as a population-based cost description from the perspective of the Italian National Health Service. Costs occurred during a defined time period for a cross-section of patients at varying stages of their disease were measured. The total cancer care cost was €81,170,121 (11.1% of total local health expenditure), with a cost per patient of €7741.17 and a cost per capita of €204.62. Surgical, inpatient and day-hospital medical admissions, radiotherapy, drugs, outpatient care, emergency admissions, and home and hospice care accounted for 21.2%, 24.1%, 6.2%, 28.2%, 14.0%, 0.9%, and 5.4% of the total cost, respectively. The highest cost items included drugs (cost per capita, €22.95; 11.2% of total cost) and medical admissions (€14.51; 7.1%) for blood cancer, and surgical (€14.56; 7.1%) and medical admissions (€13.60; 6.6%) for gastrointestinal cancer. The information extracted allows multidisciplinary cancer care teams to be more aware of the costs of their clinical decisions.

摘要

为了更有效地利用意大利国家卫生服务体系资助的医疗资源,意大利北部一个地区癌症网络开发了一种新的数据处理策略,结合了来自多个来源的信息。目标是计算六个疾病组的 10486 名患者的年度总护理路径成本。该评估是从意大利国家卫生服务体系的角度对基于人群的成本进行描述。评估期间,对处于不同疾病阶段的患者的一个横断面进行了一段时间的成本测量。癌症总护理费用为 8117.0121 万欧元(占当地卫生总支出的 11.1%),每位患者的费用为 7741.17 欧元,人均费用为 204.62 欧元。手术、住院和日间医院医疗入院、放疗、药物、门诊护理、急诊入院、家庭和临终关怀护理分别占总费用的 21.2%、24.1%、6.2%、28.2%、14.0%、0.9%和 5.4%。最高的费用项目包括药物(人均费用 22.95 欧元;占总费用的 11.2%)和血液癌的医疗入院(人均费用 14.51 欧元;占 7.1%),以及胃肠道癌的手术(人均费用 14.56 欧元;占 7.1%)和医疗入院(人均费用 13.60 欧元;占 6.6%)。提取的信息使多学科癌症护理团队能够更好地了解其临床决策的成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedf/7369964/1bdd9682c6a2/ijerph-17-04765-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedf/7369964/7ee46abb13c5/ijerph-17-04765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedf/7369964/1bdd9682c6a2/ijerph-17-04765-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedf/7369964/7ee46abb13c5/ijerph-17-04765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cedf/7369964/1bdd9682c6a2/ijerph-17-04765-g002.jpg

相似文献

1
Assessment of Cancer Care Costs in Disease-Specific Cancer Care Pathways.疾病特异性癌症护理路径中的癌症护理成本评估。
Int J Environ Res Public Health. 2020 Jul 2;17(13):4765. doi: 10.3390/ijerph17134765.
2
Economic burden of cancer across the European Union: a population-based cost analysis.欧盟癌症的经济负担:基于人群的成本分析。
Lancet Oncol. 2013 Nov;14(12):1165-74. doi: 10.1016/S1470-2045(13)70442-X. Epub 2013 Oct 14.
3
The costs of childhood epilepsy in Italy: comparative findings from three health care settings.意大利儿童癫痫的成本:来自三种医疗保健环境的比较结果。
Epilepsia. 2001 May;42(5):641-6. doi: 10.1046/j.1528-1157.2001.27300.x.
4
Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.意大利北部某地区糖尿病的流行病学趋势及直接成本:2012年健康管理记录分析,《LHT》第20期,维罗纳。
Prim Care Diabetes. 2017 Dec;11(6):570-576. doi: 10.1016/j.pcd.2017.06.001. Epub 2017 Jun 27.
5
Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016.实现全民健康覆盖所需的资金和服务:利用全球、区域和国家 1990 年至 2016 年门诊就诊和住院人次以及 1995 年至 2016 年单位成本的估计数据。
Lancet Public Health. 2019 Jan;4(1):e49-e73. doi: 10.1016/S2468-2667(18)30213-5. Epub 2018 Dec 12.
6
Incremental Health Care Expenditure of Chronic Cutaneous Ulcers in the United States.美国慢性皮肤溃疡的增量医疗支出。
JAMA Dermatol. 2019 Jun 1;155(6):694-699. doi: 10.1001/jamadermatol.2018.5942.
7
Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.糖尿病患者和非糖尿病患者的直接医疗费用:意大利都灵基于人群的研究。
Nutr Metab Cardiovasc Dis. 2012 Aug;22(8):684-90. doi: 10.1016/j.numecd.2011.04.007. Epub 2011 Sep 9.
8
Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.个体和并发非传染性疾病的卫生系统成本:来自新西兰的公共资助卫生事件分析。
PLoS Med. 2019 Jan 8;16(1):e1002716. doi: 10.1371/journal.pmed.1002716. eCollection 2019 Jan.
9
Economic burden of diverticular disease: An observational analysis based on real world data from an Italian region.基于意大利某地区真实世界数据的观察性分析:憩室疾病的经济负担。
Dig Liver Dis. 2017 Sep;49(9):1003-1008. doi: 10.1016/j.dld.2017.05.024. Epub 2017 Jun 8.
10
Resource implications of palliative chemotherapy for ovarian cancer.卵巢癌姑息化疗的资源影响
J Clin Oncol. 1997 Mar;15(3):1000-7. doi: 10.1200/JCO.1997.15.3.1000.

引用本文的文献

1
Estimation of lifetime costs for patients receiving a transplant: the case of liver transplantation related to hepatitis B in Italy.估计接受移植的患者的终身费用:以意大利乙型肝炎相关肝移植为例。
Front Public Health. 2024 Jul 3;12:1328782. doi: 10.3389/fpubh.2024.1328782. eCollection 2024.
2
New Methacrylated Biopolymer-Based Hydrogels as Localized Drug Delivery Systems in Skin Cancer Therapy.新型甲基丙烯酸化生物聚合物基水凝胶作为皮肤癌治疗中的局部给药系统
Gels. 2023 May 1;9(5):371. doi: 10.3390/gels9050371.
3
Factors influencing the delivery of cancer pathways: a summary of the literature.

本文引用的文献

1
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
2
Management of hepatitis C positive patients undergoing active treatment for malignancies: A position paper from the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Malattie Infettive e Tropicali (SIMIT).丙型肝炎阳性患者在积极治疗恶性肿瘤时的管理:意大利肿瘤学会(AIOM)和意大利传染病与热带病学会(SIMIT)的立场文件。
Semin Oncol. 2018 Oct;45(5-6):259-263. doi: 10.1053/j.seminoncol.2018.07.004. Epub 2018 Oct 25.
3
影响癌症通路实施的因素:文献综述。
J Health Organ Manag. 2021 Mar 24;35(9):121-139. doi: 10.1108/JHOM-05-2020-0192.
4
The Economic Impact of Rectal Cancer: A Population-Based Study in Italy.意大利基于人群的直肠癌经济影响研究。
Int J Environ Res Public Health. 2021 Jan 8;18(2):474. doi: 10.3390/ijerph18020474.
Reliability and validity assessment of administrative databases in measuring the quality of rectal cancer management.行政数据库在衡量直肠癌管理质量方面的可靠性和有效性评估。
Tumori. 2018 Jan-Feb;104(1):51-59. doi: 10.5301/tj.5000708.
4
The cost of cancer treatment in Portugal.葡萄牙癌症治疗的费用。
Ecancermedicalscience. 2017 Sep 6;11:765. doi: 10.3332/ecancer.2017.765. eCollection 2017.
5
The challenge of sustainability in healthcare systems: Frequency and cost of inappropriate patterns of breast cancer care (the E.Pic.A study).医疗保健系统中的可持续性挑战:乳腺癌不适当治疗模式的频率和成本(E.Pic.A研究)
Breast. 2017 Aug;34:103-107. doi: 10.1016/j.breast.2017.05.007. Epub 2017 May 27.
6
Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study.腺瘤监测与结直肠癌发病率:一项回顾性、多中心、队列研究。
Lancet Oncol. 2017 Jun;18(6):823-834. doi: 10.1016/S1470-2045(17)30187-0. Epub 2017 Apr 28.
7
Optimising allocative value for populations.优化人群的分配价值。
J R Soc Med. 2017 Apr;110(4):138-143. doi: 10.1177/0141076817698653.
8
Disability, Work Absenteeism, Sickness Benefits, and Cancer in Selected European OECD Countries-Forecasts to 2020.部分经合组织欧洲国家的残疾、旷工、疾病津贴与癌症——至2020年的预测
Front Public Health. 2017 Feb 27;5:23. doi: 10.3389/fpubh.2017.00023. eCollection 2017.
9
Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014.1980 - 2014年美国各县癌症死亡率差异的趋势与模式
JAMA. 2017 Jan 24;317(4):388-406. doi: 10.1001/jama.2016.20324.
10
Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis.放射治疗的成本评估:我们了解什么?一项欧洲放射肿瘤学会-健康经济研究优化组织分析。
Radiother Oncol. 2016 Dec;121(3):468-474. doi: 10.1016/j.radonc.2016.12.002.